These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26352735)

  • 1. Origin of fibrosing cells in systemic sclerosis.
    Ebmeier S; Horsley V
    Curr Opin Rheumatol; 2015 Nov; 27(6):555-62. PubMed ID: 26352735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.
    Wei J; Bhattacharyya S; Tourtellotte WG; Varga J
    Autoimmun Rev; 2011 Mar; 10(5):267-75. PubMed ID: 20863909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis.
    Postlethwaite AE; Shigemitsu H; Kanangat S
    Curr Opin Rheumatol; 2004 Nov; 16(6):733-8. PubMed ID: 15577612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.
    Cepeda EJ; Reveille JD
    Curr Opin Rheumatol; 2004 Nov; 16(6):723-32. PubMed ID: 15577611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast and endothelial apoptosis in systemic sclerosis.
    Jun JB; Kuechle M; Harlan JM; Elkon KB
    Curr Opin Rheumatol; 2003 Nov; 15(6):756-60. PubMed ID: 14569206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfacial Adipose Tissue in Systemic Sclerosis.
    Kruglikov IL
    Curr Rheumatol Rep; 2017 Jan; 19(1):4. PubMed ID: 28138823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
    Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
    J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vessels Contribute to Fibrosis in Systemic Sclerosis.
    Di Benedetto P; Ruscitti P; Liakouli V; Cipriani P; Giacomelli R
    Isr Med Assoc J; 2019 Jul; 21(7):471-474. PubMed ID: 31507123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells.
    Gilbane AJ; Denton CP; Holmes AM
    Arthritis Res Ther; 2013; 15(3):215. PubMed ID: 23796020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosis--a lethal component of systemic sclerosis.
    Ho YY; Lagares D; Tager AM; Kapoor M
    Nat Rev Rheumatol; 2014 Jul; 10(7):390-402. PubMed ID: 24752182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
    Asano Y; Takahashi T; Saigusa R
    J Dermatol Sci; 2019 May; 94(2):259-265. PubMed ID: 31079997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of endothelial cells to tissue fibrosis.
    Romano E; Rosa I; Fioretto BS; Manetti M
    Curr Opin Rheumatol; 2024 Jan; 36(1):52-60. PubMed ID: 37582200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis.
    Rajkumar VS; Howell K; Csiszar K; Denton CP; Black CM; Abraham DJ
    Arthritis Res Ther; 2005; 7(5):R1113-23. PubMed ID: 16207328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
    Luckhardt TR; Thannickal VJ
    Curr Opin Rheumatol; 2015 Nov; 27(6):571-6. PubMed ID: 26398012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial-to-mesenchymal transition in systemic sclerosis.
    Di Benedetto P; Ruscitti P; Berardicurti O; Vomero M; Navarini L; Dolo V; Cipriani P; Giacomelli R
    Clin Exp Immunol; 2021 Jul; 205(1):12-27. PubMed ID: 33772754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of systemic sclerosis (scleroderma).
    Rosendahl AH; Schönborn K; Krieg T
    Kaohsiung J Med Sci; 2022 Mar; 38(3):187-195. PubMed ID: 35234358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
    Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrogenesis, novel lessons from animal models.
    De Langhe E; Lories R
    Semin Immunopathol; 2015 Sep; 37(5):565-74. PubMed ID: 26141608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.